These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3115453)

  • 1. Bromocriptine induced impotence in Parkinson's disease.
    Cleeves L; Findley LJ
    Br Med J (Clin Res Ed); 1987 Aug; 295(6594):367-8. PubMed ID: 3115453
    [No Abstract]   [Full Text] [Related]  

  • 2. Pleuropulmonary fibrosis due to bromocriptine treatment for Parkinson's disease.
    Todman DH; Oliver WA; Edwards RL
    Clin Exp Neurol; 1990; 27():79-82. PubMed ID: 2129961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bromocriptine mesylate in Parkinson's disease.
    Lieberman A; Kupersmith M; Neophytides A; Casson I; Durso R; Foo SH; Khayali M; Tartaro T
    N Y State J Med; 1979 Oct; 79(11):1689-92. PubMed ID: 290866
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of Parkinson's disease with bromocriptine].
    Castaigne P; Laplane D; Bousser MG; Bories F
    Nouv Presse Med; 1976 Apr; 6(17):1482. PubMed ID: 1037400
    [No Abstract]   [Full Text] [Related]  

  • 5. Levodopa compared with bromocriptine in the treatment of Parkinson's disease.
    Godwin-Austen RB
    Adv Biochem Psychopharmacol; 1980; 23():261-5. PubMed ID: 7395616
    [No Abstract]   [Full Text] [Related]  

  • 6. A comparative study of bromocriptine and levodopa in Parkinson's disease.
    Duvoisin RC; Mendoza MM; Yahr MD
    Adv Biochem Psychopharmacol; 1980; 23():271-5. PubMed ID: 7395618
    [No Abstract]   [Full Text] [Related]  

  • 7. Retroperitoneal fibrosis and treatment of Parkinson's disease with high doses of bromocriptine.
    Demonet JF; Rostin M; Dueymes JM; Ioualalen A; Montastruc JL; Rascol A
    Clin Neuropharmacol; 1986; 9(2):200-1. PubMed ID: 3708605
    [No Abstract]   [Full Text] [Related]  

  • 8. The role of bromocriptine in the treatment of Parkinson's disease.
    Stern GM; Lees AJ; Shaw KM; Lander CM
    Adv Biochem Psychopharmacol; 1980; 23():267-70. PubMed ID: 7395617
    [No Abstract]   [Full Text] [Related]  

  • 9. Bromocriptine and Parkinson's disease: a 16-hour clinical evaluation.
    Grøn U; Friis ML; Pakkenberg H
    Acta Neurol Scand; 1980 Feb; 61(2):131-6. PubMed ID: 6994422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bromocriptine in Parkinson's disease.
    Stern G; Lees A
    Br J Hosp Med; 1978 Dec; 20(6):666-70. PubMed ID: 743580
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of the effects of bromocriptine and levodopa in Parkinson's disease.
    Godwin-Austen RB; Smith NJ
    J Neurol Neurosurg Psychiatry; 1977 May; 40(5):479-82. PubMed ID: 330825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Bromocriptine (Parlodel) in the treatment of Parkinson's disease. Summary of 7 years' experience].
    Delwaide PJ; Schoenen J
    Rev Med Liege; 1983 May; 38(9):362-6. PubMed ID: 6867529
    [No Abstract]   [Full Text] [Related]  

  • 13. Parkinson's disease: an open label trial of pergolide in patients failing bromocriptine therapy.
    Factor SA; Sanchez-Ramos JR; Weiner WJ
    J Neurol Neurosurg Psychiatry; 1988 Apr; 51(4):529-33. PubMed ID: 3288717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Bromocriptine versus levodopa in the early treatment of Parkinson's disease. 1st results after 2 years].
    Montastruc JL; Rascol O; Rascol A
    Therapie; 1988; 43(6):461-3. PubMed ID: 3227512
    [No Abstract]   [Full Text] [Related]  

  • 15. Further experiences with low doses of bromocriptine in Parkinson's disease.
    Fahn S; Côté LJ; Barrett RE; Snider SR
    Adv Biochem Psychopharmacol; 1980; 23():255-60. PubMed ID: 7395615
    [No Abstract]   [Full Text] [Related]  

  • 16. Sustained bromocriptine therapy in previously untreated patients with Parkinson's disease.
    Lees AJ; Stern GM
    J Neurol Neurosurg Psychiatry; 1981 Nov; 44(11):1020-3. PubMed ID: 7334388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term effects of bromocriptine given to de novo patients with idiopathic Parkinson's disease.
    Stern G; Lees A
    Adv Neurol; 1987; 45():525-7. PubMed ID: 3103395
    [No Abstract]   [Full Text] [Related]  

  • 18. Sustained bromocriptine therapy in 50 previously untreated patients with Parkinson's disease.
    Stern GM; Lees AJ
    Adv Neurol; 1983; 37():17-21. PubMed ID: 6858771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of parkinson's disease with bromocriptine.
    Lieberman A; Kupersmith M; Estey E; Goldstein M
    N Engl J Med; 1976 Dec; 295(25):1400-4. PubMed ID: 989885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bromocriptine in the treatment of Parkinson's disease: a double-blind study against L-dopa/carbidopa.
    Gawel M; Riopelle R; Libman I; Bouchard S
    Adv Neurol; 1987; 45():535-8. PubMed ID: 3548263
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.